Medreich Limited Codeine Export Data — India (DGFT 2022–2026)

Name: Medreich Limited Codeine Export Records India — #3 Exporter, 145 Shipments, $7.3M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Codeine

India Pharmaceutical Trade Intelligence

$109.2M30 Suppliers35 CountriesHS 30049069

ExportsIndia → UNITED KINGDOM57.2%India → SOUTH AFRICA30.5%

ImportsUNITED KINGDOM → India$1.3K AUSTRALIA → India$1.2K

#1 Supplier: WOCKHARDT LIMITED #1 Buyer: WOCKHARDT UK

Medreich Limited — Codeine Exporter #3 | $7.3M Trade Value | TransData Nexus | TransData Nexus

Medreich Limited — Codeine Exporter Profile

Indian Pharmaceutical Exporter · #3 for Codeine · $7.3M export value · DGFT Verified

Medreich Limited is the #3 Indian exporter of Codeine with $7.3M in export value and 145 verified shipments. Medreich Limited holds a 6.6% market share in Codeine exports across 4 countries. The company exports 42 pharmaceutical products worth $224.8M across 15 therapeutic categories.

Medreich Limited — Codeine Export Profile: Buyers & Destinations

Medreich Limited Codeine export treemap — buyers and destination countries | TransData Nexus

Where Does Medreich Limited Export Codeine?

Country	Value	Shipments	Share
UNITED KINGDOM	$3.0M	70	63.9%
NEW ZEALAND	$957.3K	35	20.3%
AUSTRALIA	$621.6K	37	13.2%
IRELAND	$123.6K	3

Who Are the Top Buyers of Codeine from Medreich Limited?

Buyer	Country	Value	Orders
MEDREICH PLC	UNITED KINGDOM	$2.9M	68
VIATRIS NEW ZEALAND	NEW ZEALAND	$781.7K	30
MEDREICH AUSTRALIA PTY LTD	AUSTRALIA	$482.3K	28
MYLAN NEW ZEALAND LTD	NEW ZEALAND	$175.6K	5
AZURE PHARMACETICALS	IRELAND	$123.6K	3
MEDREICH PLC WARWICK HOUSE	UNITED KINGDOM	$100.0K	2
MEDREICH AUSTRALIA PTY LIMITED	AUSTRALIA	$92.3K	3
VIATRIS PTY LTD	AUSTRALIA	$22.4K	4
VIATRIS PTY LIMITED	AUSTRALIA	$19.9K	1
MEDREICH AUSTRALIA PTY LTD.	AUSTRALIA	$4.7K	1

Medreich Limited supplies Codeine to 10 buyers globally. The largest buyer is MEDREICH PLC (UNITED KINGDOM), followed by VIATRIS NEW ZEALAND (NEW ZEALAND) and MEDREICH AUSTRALIA PTY LTD (AUSTRALIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Codeine Formulations Does Medreich Limited Export?

Product Description / Formulation	Value	Shipments
PARACETAMOL 500MG+CODEINE PHOSPHATE 8MG	$426.1K	16
PARACETAMOL 500MG+CODEINE 15MG TABLETS	$423.7K	10
PARACETAMOL 500MG+CODEINE 15MG TABLETS (	$338.7K	7
IBUPROFEN 200MG +CODEINE PHOSPHATE 12.8M	$101.8K	3
PARACETAMOL 500MG CODEINE 15MG TABLETS 1303724 CO CODAMOL TABLETS QTY 49170 NOS 10X10S	$100.0K	2
PARACETAMOL 500MG+CODEINE PHOSPHATE 15MG	$74.5K	4
IBUPROFEN 200MG + CODEINE PHOSPHATE 12.8	$65.1K	3
PARACETAMOL 500MG + CODEINE 15MG TABLETS	$50.0K	1
PARACETAMOL 500MG+CODEINE 15MG TABLETS(C	$50.0K	1
PARACETAMOL 500MG + CODEINE 15MG TABLETSCO- CODAMOL TABLETS PACK SIZE -10X10S29237 PACKS	$50.0K	1

Medreich Limited exports 106 distinct Codeine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PARACETAMOL 500MG+CODEINE PHOSPHATE 8MG with 16 shipments worth $426.1K.

How Does Medreich Limited Compare to Nearest Codeine Exporters?

Exporters ranked immediately above and below #3 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
2	ADCOCK INGRAM LIMITED	$33.3M	964	3	$34.5K
1	WOCKHARDT LIMITED	$9.6M	191	1	$50.0K
3	MEDREICH LIMITED ★	$7.3M	145	4	$50.0K
4	SANOFI INDIA LIMITED	$3.8M	75	2	$50.0K
6	CIPLA LIMITED	$1.4M	211	3	$6.7K

Medreich Limited ranks #3 among 30 Indian Codeine exporters. Average shipment value of $50.0K compared to the market average of $2.0M. The closest competitors by value are ADCOCK INGRAM LIMITED and WOCKHARDT LIMITED.

Which Indian Ports Ship Codeine Exports?

Port	Shipments	% Share
BANGALORE ICD	657	36.8%
BANGALORE ICD (INWFD6)	205	11.5%
NHAVA SHEVA SEA (INNSA1)	171	9.6%
JNPT/ NHAVA SHEVA SEA	135	7.6%
JNPT	114	6.4%
SAHAR AIR	80	4.5%
Bangalore	59	3.3%
Bangalore ICD	34	1.9%

Geopolitical & Trade Policy Impact on Medreich Limited's Codeine Exports

The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like Medreich Limited. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, resulting in increased shipping costs and extended transit times. Major shipping lines have implemented 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU, directly impacting the cost structures of exporters relying on these routes. (sgeexport.com)

Conversely, the US-China trade tensions have prompted the United States to seek alternative sources for pharmaceuticals, potentially benefiting Indian exporters. However, the imposition of tariffs on pharmaceutical imports by the US poses a risk to Indian companies, as higher tariffs could render low-margin generic drugs unprofitable, leading to market exits and exacerbating drug shortages in the US. (cfo.economictimes.indiatimes.com)

The recent India-European Union Free Trade Agreement (FTA), signed in January 2026, offers a favorable development for Medreich. The FTA eliminates tariffs on Indian pharmaceutical products entering the EU, providing immediate cost relief and enhancing market access. This agreement is expected to significantly boost India's pharmaceutical exports to Europe, creating new opportunities for companies like Medreich to expand their presence in the EU market. (en.wikipedia.org)

Medreich Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The US Food and Drug Administration (FDA), World Health Organization (WHO), and European Union Good Manufacturing Practices (EU GMP) set stringent quality requirements that companies must adhere to for market access. Recent regulatory frameworks have increased compliance costs by an average of 18.7%, leading to a 15.2% reduction in export volumes to the US in the first quarter of 2025. (transdatanexus.com)

For Medreich Limited, maintaining compliance with these evolving standards is crucial to sustaining and expanding its export markets. Investments in quality assurance, regular audits, and staying abreast of regulatory changes are essential strategies to navigate this complex landscape.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Codeine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Medreich Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 145 individual customs records matching Medreich Limited exporting Codeine, covering 106 formulations to 4 countries via 10 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 35+ countries, 82+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Codeine

Codeine

Medreich Limited — Codeine Exporter Profile

Medreich Limited — Codeine Export Profile: Buyers & Destinations

Where Does Medreich Limited Export Codeine?

Who Are the Top Buyers of Codeine from Medreich Limited?

What Is India's Total Codeine Export Value and How Much Does Medreich Limited Contribute?

What Is the Average Shipment Value for Medreich Limited's Codeine Exports?

How Does Medreich Limited Compare to Other Indian Codeine Exporters?

What Codeine Formulations Does Medreich Limited Export?

Regulatory Requirements: Exporting Codeine to Key Markets

United Kingdom — MHRA

Australia — TGA

How Does Medreich Limited Compare to Nearest Codeine Exporters?

Which Indian Ports Ship Codeine Exports?

What Other Analgesics & Antipyretics Products Does Medreich Limited Export?

Geopolitical & Trade Policy Impact on Medreich Limited's Codeine Exports

Medreich Limited — Regulatory Compliance & Quality Standards

About Medreich Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Codeine Export Data from Medreich Limited

Codeine Stats

Company Overview

Top Products by Medreich Limited

Related Analysis

Need Detailed Export Data?

Data Source